FIELD: medicine.
SUBSTANCE: invention relates to medicine and namely to clinical laboratory diagnostics, andrology, and reproductive medicine. The invention can be used to assess the risk of teratozoospermia in men. One should determine the activity of amylase in serum and sperm plasma. The hematosperm amylase coefficient is calculated as the ratio of the amylase activity in the blood serum to the amylase activity in the sperm plasma, and when the hematosperm amylase coefficient is less than 7.93, a high risk of teratozoospermia is predicted; if the hemato-sperm coefficient of amylase is greater than or equal to 7.93, a low risk of teratozoospermia is predicted.
EFFECT: invention allows to determine with high accuracy the risk of teratozoospermia by determining the most sensitive and specific indicators.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING RISK OF OLIGOZOOSPERMIA IN MEN WITH NORMOZOOSPERMIA | 2020 |
|
RU2736002C1 |
| METHOD FOR DETERMINING QUALITY OF EJACULATE IN MALES BY ACTIVITY OF CREATINE PHOSPHOKINASE IN SEMINAL PLASMA | 2020 |
|
RU2732968C1 |
| METHOD FOR DIAGNOSING EJACULATE FERTILITY IN IDIOPATHIC INFERTILITY | 2022 |
|
RU2789239C1 |
| METHOD OF PREDICTION OF IDIOPATHIC MALE INFERTILITY BASED ON ANALYSIS OF NUCLEOTIDE VARIANTS IN MITOCHONDRIAL CYTOCHROME B GENE | 2022 |
|
RU2800406C1 |
| METHOD FOR PREDICTING NON-DEVELOPING PREGNANCY ASSOCIATED WITH CHROMOSOMAL ABNORMALITIES OF THE EMBRYO | 2021 |
|
RU2760499C1 |
| METHOD FOR PREDICTION OF HIGH DEGREE OF DNA FRAGMENTATION AND MISCARRIAGE IN A PAIR | 2019 |
|
RU2703455C1 |
| METHOD FOR PREDICTING MALE INFERTILITY BASED ON SPERM DNA FRAGMENTATION ANALYSIS | 2023 |
|
RU2804207C1 |
| METHOD FOR PREDICTION OF EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETARY TERATOZOSPERMIA | 2021 |
|
RU2759539C1 |
| METHOD OF DIAGNOSING EARLY REPRODUCTIVE DISORDERS IN MEN | 2009 |
|
RU2413949C1 |
| METHOD OF TREATING AUTOIMMUNE MALE STERILITY | 2010 |
|
RU2430725C1 |
